Recombinant interferon beta-1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.
CITATION STYLE
Gupta, M., Yamauchi, P. S., Bagot, M., Szepietowski, J., Bhatia, S., Lotti, T., & Goldust, M. (2020). Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report. Clinical Case Reports, 8(9), 1647–1650. https://doi.org/10.1002/ccr3.2971
Mendeley helps you to discover research relevant for your work.